Studies on the conditions for cyclic AMP formation in homogenised and intact fat cells by use of  3 H-ATP and  3 H-adenine.
D000225:Adenine / Q000378:metabolism*; D000244:Adenosine Diphosphate / Q000096:biosynthesis; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000067956:Adenylyl Cyclase Inhibitors; D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002477:Cells / Q000378:metabolism; D000242:Cyclic AMP / Q000096:biosynthesis*; D004789:Enzyme Activation; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013565:Sympatholytics / Q000494:pharmacology; D013806:Theophylline / Q000008:administration & dosage / Q000494:pharmacology; D014316:Tritium
D000067956:Adenylyl Cyclase Inhibitors; D013565:Sympatholytics; D014316:Tritium; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D013806:Theophylline; D000242:Cyclic AMP; D008274:Magnesium; D000225:Adenine; D009638:Norepinephrine